Skip to main content
Sunday, July 26, 2026
BTC $64,431 ▲ 0.18%
GOKHSHTEIN.
Live WirePoliticsMarketsDigital AssetsTechnologySports
DeFi & On-ChainU.S. EquitiesMacro & RatesResearch
SubscribeGMarkets
Live WirePoliticsMarketsDigital AssetsTechnologySportsDeFi & On-ChainU.S. EquitiesMacro & RatesResearchGMarkets ↗
SubscribeGMarkets →
LIVE
ADA$0.165up+0.46%ETH$1,879up+0.29%LINK$8.40up+0.29%SOL$74.83up+0.48%BTC$64,431up+0.18%XRP$1.10up+0.21%S&P 5007,412up+0.05%Nasdaq24,976down−0.64%Dow51,947up+0.46%RUT2,930down−0.35%TNX4.68%down−0.51%TYX5.16%down−0.17%FVX4.43%down−0.78%IRX3.81%up+0.13%VIX18.58down−0.64%GOLD$4,070.80up+0.51%SILVER$58.91up+1.47%OIL$89.31down−3.12%DXY101.47down−0.00%NVDA$206.84down−0.92%AAPL$333.02up+3.53%TSLA$313.03down−2.08%META$595.19down−1.80%MSFT$381.70up+0.03%AMZN$232.11down−0.66%GOOGL$319.74up+0.65%Fear & Greed26 — FearADA$0.165up+0.46%ETH$1,879up+0.29%LINK$8.40up+0.29%SOL$74.83up+0.48%BTC$64,431up+0.18%XRP$1.10up+0.21%S&P 5007,412up+0.05%Nasdaq24,976down−0.64%Dow51,947up+0.46%RUT2,930down−0.35%TNX4.68%down−0.51%TYX5.16%down−0.17%FVX4.43%down−0.78%IRX3.81%up+0.13%VIX18.58down−0.64%GOLD$4,070.80up+0.51%SILVER$58.91up+1.47%OIL$89.31down−3.12%DXY101.47down−0.00%NVDA$206.84down−0.92%AAPL$333.02up+3.53%TSLA$313.03down−2.08%META$595.19down−1.80%MSFT$381.70up+0.03%AMZN$232.11down−0.66%GOOGL$319.74up+0.65%Fear & Greed26 — Fear
GOKHSHTEIN.
Media · Est. 2019
The front page of everything. Breaking news and sharp analysis across politics, markets, crypto, technology, and sports — with live market data built in.
Markets
Market OverviewDigital AssetsU.S. EquitiesMacro & RatesResearch
Editorial
Politics & PolicyTechnologySports BusinessResearch
Terminal
GMarkets ↗Go PRO
Company
AboutAdvertiseSubscribe
Legal
Privacy PolicyTerms of ServiceDisclosures
© 2026 Gokhshtein Media. All rights reserved.
PrivacyTermsDisclosures
Tag

medical devices

3 articles

Integer Holdings Q1 Beat Drives $110 Target on MedTech Demand
U.S. Equities69d ago
Integer Holdings Q1 Beat Drives $110 Target on MedTech Demand
Integer Holdings reported first-quarter revenue of $420 million, exceeding analyst forecasts by five percent as strong demand for cardiac and neuromodulation devices drove results
Stryker's $400 Target Looms as Advanced Orthopedics Fuel Rapid Athlete Returns
U.S. Equities94d ago
Stryker's $400 Target Looms as Advanced Orthopedics Fuel Rapid Athlete Returns
Breakthroughs in sports medicine, exemplified by Jayson Tatum's record Achilles recovery, position Stryker for substantial upside as demand for advanced orthopedic solutions surges across healthcare.
Epia Neuro's BCI: A $5B Market Opportunity or Niche Play?
Technology114d ago
Epia Neuro's BCI: A $5B Market Opportunity or Niche Play?
Epia Neuro's integration of a motorized glove with its brain-computer interface for stroke recovery positions it in a growing neurotech market, raising questions about scalability and long-term profitability amidst intense competition and complex reimbursement landscapes.